Paper573129
Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
Kaltenbach M and 5 others. Br Heart J, 1979. Cited by 205 papers, by iCite.
Cite this record
ConductScience Library. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Papers, record 573129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/573129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathy, Hypertrophic | Major topic |
| Verapamil | Major topic |
| Adult | |
| Cardiac Catheterization | |
| Coronary Angiography | |
| Coronary Vessels | |
| Electrocardiography | |
| Female | |
| Heart | |
| Hemodynamics | |
| Humans | |
| Male | |
| Myocardial Contraction |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 73643 | Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. | Lancet | 1976 | https://conductscience.org/library/papers/73643 | PubMed |
| 2 | 17415 | [Drug therapy of coronary heart disease (author's transl)]. | Arzneimittelforschung | 1977 | https://conductscience.org/library/papers/17415 | PubMed |
| 3 | 4277967 | [Width and cross section of epicardial coronary arteries in relation to myocardial hypertrophy]. | Z Kardiol | 1974 | https://conductscience.org/library/papers/4277967 | PubMed |
| 4 | 4191245 | Congestive and hypertrophic cardiomyopathies. A decade of study. | Lancet | 1970 | https://conductscience.org/library/papers/4191245 | PubMed |
| 5 | 1169134 | Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. | Circulation | 1975 | https://conductscience.org/library/papers/1169134 | PubMed |
| 6 | 945645 | [Late results of surgery in muscular subvalvular aortic stenosis]. | Z Kardiol | 1976 | https://conductscience.org/library/papers/945645 | PubMed |
| 7 | 4586631 | Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. | Br Heart J | 1973 | https://conductscience.org/library/papers/4586631 | PubMed |
| 8 | 8298 | [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)]. | Dtsch Med Wochenschr | 1976 | https://conductscience.org/library/papers/8298 | PubMed |
| 9 | 4735938 | Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. | Am J Cardiol | 1973 | https://conductscience.org/library/papers/4735938 | PubMed |
| 10 | 936724 | [Course observations of hypertrophic obstructive myocardiopathy]. | Z Kardiol | 1976 | https://conductscience.org/library/papers/936724 | PubMed |
| 11 | 1122800 | [Cine-angiographic determination of ventricular volumes with the help of a computer (author's transl)]. | Dtsch Med Wochenschr | 1975 | https://conductscience.org/library/papers/1122800 | PubMed |
| 12 | 5462284 | Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. | Br Heart J | 1970 | https://conductscience.org/library/papers/5462284 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41649583 | CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy. | Eur J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41649583 | PubMed |
| 40993768 | Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy. | J Cardiovasc Imaging | 2025 | https://conductscience.org/library/papers/40993768 | PubMed |
| 40377024 | Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. | Eur Heart J Cardiovasc Pharmacother | 2025 | https://conductscience.org/library/papers/40377024 | PubMed |
| 39943699 | Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/39943699 | PubMed |
| 39330348 | Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review. | J Cardiovasc Dev Dis | 2024 | https://conductscience.org/library/papers/39330348 | PubMed |
| 39175632 | Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39175632 | PubMed |
| 38269637 | A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy. | Clin Cardiol | 2024 | https://conductscience.org/library/papers/38269637 | PubMed |
| 37377648 | Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/37377648 | PubMed |
| 36741099 | Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy. | Heart Int | 2022 | https://conductscience.org/library/papers/36741099 | PubMed |
| 32185419 | [Hypertrophic cardiomyopathy]. | Herz | 2020 | https://conductscience.org/library/papers/32185419 | PubMed |
| 25657602 | Hypertrophic cardiomyopathy: a review. | Clin Med Insights Cardiol | 2014 | https://conductscience.org/library/papers/25657602 | PubMed |
| 25634554 | Targets for therapy in sarcomeric cardiomyopathies. | Cardiovasc Res | 2015 | https://conductscience.org/library/papers/25634554 | PubMed |
| 25563291 | Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. | Curr Cardiol Rev | 2016 | https://conductscience.org/library/papers/25563291 | PubMed |
| 22567198 | Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature. | Heart Views | 2011 | https://conductscience.org/library/papers/22567198 | PubMed |
| 18610277 | Treatment of hypertrophic obstructive cardiomyopathy with verapamil. | Br Heart J | 1980 | https://conductscience.org/library/papers/18610277 | PubMed |
| 15216199 | Calcium antagonists: A new class of therapeutic agents. | Cardiovasc Dis | 1981 | https://conductscience.org/library/papers/15216199 | PubMed |
| 11714423 | Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy. | Curr Control Trials Cardiovasc Med | 2000 | https://conductscience.org/library/papers/11714423 | PubMed |
| 9594536 | [Clinical picture and therapy of hypertrophic cardiomyopathy]. | Med Klin (Munich) | 1998 | https://conductscience.org/library/papers/9594536 | PubMed |
| 8924052 | Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment? | Cardiovasc Drugs Ther | 1996 | https://conductscience.org/library/papers/8924052 | PubMed |
| 7298378 | The role of calcium in the toxicity of the myocardium. | Histochem J | 1981 | https://conductscience.org/library/papers/7298378 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/573129
GET https://conductscience.org/api/papers/v1/573129/cited_by?page=2